Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Celestica | CLS | Nov 26, 2024 | 86.67 | +1.25 |
Celldex Therapeutics | CLDX | Nov 26, 2024 | 26.76 | -4.90 |
Cellebrite | CLBT | Nov 26, 2024 | 19.93 | -0.30 |
Cellectar Biosciences | CLRB | Nov 26, 2024 | 1.56 | -0.64 |
Cellectis ADR | CLLS | Nov 26, 2024 | 2.14 | +9.18 |
Celsius | CELH | Nov 26, 2024 | 27.60 | -7.23 |
Celularity A | CELU | Nov 26, 2024 | 2.85 | -5.00 |
Cementos Pacasmayo ADR | CPAC | Nov 26, 2024 | 5.66 | +0.35 |
CEMEX ADR | CX | Nov 26, 2024 | 5.44 | -5.39 |
Cemtrex | CETX | Nov 26, 2024 | 3.20 | +2 803.81 |
Cencora | COR | Nov 26, 2024 | 248.45 | +1.73 |
Cenntro | CENN | Nov 26, 2024 | 1.21 | -3.20 |
Cenovus Energy | CVE | Nov 26, 2024 | 15.48 | -2.27 |
Centene | CNC | Nov 26, 2024 | 60.00 | -2.33 |
CenterPoint Energy | CNP | Nov 26, 2024 | 32.53 | +0.15 |
Centerra Gold | CGAU | Nov 26, 2024 | 5.91 | -0.84 |
Centerspace | CSR-C | Nov 26, 2024 | 24.98 | 0.00 |
Centessa Pharmaceuticals ADR | CNTA | Nov 26, 2024 | 17.30 | +1.17 |
Centrais Electricas Brasileiras B ADR | EBR-B | Nov 26, 2024 | 6.97 | +0.72 |
Centrais Eletricas Brasileiras ADR | EBR | Nov 26, 2024 | 6.30 | +1.61 |
Central Garden & Pet | CENT | Nov 26, 2024 | 39.83 | +2.63 |
Central Garden & Pet A | CENTA | Nov 26, 2024 | 33.76 | +1.63 |
Central Pacific Financial | CPF | Nov 26, 2024 | 32.23 | -1.23 |
Central Plains Bancshares | CPBI | Nov 26, 2024 | 14.45 | +0.98 |
Central Puerto ADR | CEPU | Nov 26, 2024 | 13.92 | -0.36 |
Central Securities | CET | Nov 26, 2024 | 46.90 | -0.28 |
Centrus Energy A | LEU | Nov 26, 2024 | 81.45 | -2.07 |
Centuri Holdings | CTRI | Nov 26, 2024 | 20.71 | -1.05 |
Centurion Acquisition | ALFUU | Nov 26, 2024 | 10.11 | 0.00 |
Century Aluminium | CENX | Nov 26, 2024 | 23.84 | +2.58 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.